Clinical Trials Logo

Essential Blepharospasm clinical trials

View clinical trials related to Essential Blepharospasm.

Filter by:
  • None
  • Page 1

NCT ID: NCT03641950 Completed - Clinical trials for Essential Blepharospasm

The Objective of This Study is to Evaluate the Efficacy and Safety of Botulax® in Patients With Essential Blepharospasm.

Start date: April 30, 2015
Phase: Phase 4
Study type: Interventional

The purpose of this study is evaluate the efficacy and safety of Botulax® in the treatment of Essential blepharospasm.

NCT ID: NCT03216473 Completed - Clinical trials for Essential Blepharospasm

Clinical Study to Evaluate the Efficacy and Safety of Neuronox and Botox With Essential Blepharospasm

Start date: May 25, 2016
Phase: Phase 3
Study type: Interventional

This clinical study evaluates the efficacy and safety of Neuronox compared with Botox in adults with essential blepharospasm.

NCT ID: NCT01791881 Completed - Clinical trials for Essential Blepharospasm

Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of "Hugeltox Inj." in Essential Blepharospasm

Start date: April 2008
Phase: Phase 3
Study type: Interventional

To compare the efficacy and safety of Hugel-Tox (Botulinum toxin A, Hugel, Korea) against Botox in the treatment of Essential Blepharospasm and to get a regulatory approval from KFDA

NCT ID: NCT01259557 Completed - Clinical trials for Essential Blepharospasm

Efficacy and Safety Study of Meditoxin® to Treat Essential Blepharospasm

Start date: August 2010
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Meditoxin® in the treatment of Essential blepharospasm.